SGRY - Surgery Partners, Inc.

QQQ $ 472.51 $ -0.55 (-0.12 %)

DIA $ 416.99 $ 0.04 (0.01 %)

SPY $ 562.00 $ 0.53 (0.09 %)

TLT $ 101.20 $ 0.57 (0.57 %)

GLD $ 238.43 $ -0.17 (-0.07 %)

Previous Close

$ 31

Open

$ 31.36

Bid

$ 31.75 x 100

Ask

-- x --

Day's Range

$ 31.11 - $ 32.11

52 Week Range

$ 22.05 - $ 36.92

Volume

902,569

Average Volume

Market Cap

3.94B

Beta (5Y Monthly)

$ 2.11

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-06-2024	06-30-2024	10-Q
2	05-07-2024	03-31-2024	10-Q
3	02-26-2024	12-31-2023	10-K
4	11-07-2023	09-30-2023	10-Q
5	08-01-2023	06-30-2023	10-Q
6	05-02-2023	03-31-2023	10-Q
7	03-01-2023	12-31-2022	10-K
8	11-08-2022	09-30-2022	10-Q
9	08-02-2022	06-30-2022	10-Q
10	05-03-2022	03-31-2022	10-Q
11	03-01-2022	12-31-2021	10-K
12	11-03-2021	09-30-2021	10-Q
13	08-04-2021	06-30-2021	10-Q
14	05-05-2021	03-31-2021	10-Q
15	03-10-2021	12-31-2020	10-K
16	11-04-2020	09-30-2020	10-Q
17	08-05-2020	06-30-2020	10-Q
18	05-11-2020	03-31-2020	10-Q
19	03-13-2020	12-31-2019	10-K
20	11-06-2019	09-30-2019	10-Q
21	08-09-2019	06-30-2019	10-Q
22	05-10-2019	03-31-2019	10-Q
23	03-15-2019	12-31-2018	10-K
24	11-09-2018	09-30-2018	10-Q
25	08-09-2018	06-30-2018	10-Q
26	05-10-2018	03-31-2018	10-Q
27	03-16-2018	12-31-2017	10-K
28	11-09-2017	09-30-2017	10-Q
29	08-09-2017	06-30-2017	10-Q
30	05-10-2017	03-31-2017	10-Q
31	03-10-2017	12-31-2016	10-K
32	11-10-2016	09-30-2016	10-Q
33	08-10-2016	06-30-2016	10-Q
34	05-06-2016	03-31-2016	10-Q
35	03-11-2016	12-31-2015	10-K
36	11-13-2015	09-30-2015	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Benchmark Reiterates Buy on Surgery Partne...
08/26/2024 13:54:04

Benchmark analyst Bill Sutherland reiterates Surgery Partners (NASDAQ:SGRY) with a Buy and maintains $50 price target.

TPG, UnitedHealth Are Said Among Suitors F...
08/23/2024 16:59:40

- Bloomberg

concentras-post-ipo-trading-levels-based-on-its-dominant-market-position-says-analyst

Concentra's Post-IPO Trading Levels Based ...
08/20/2024 18:39:15

Concentra, a subsidiary of select medical, recently priced its IPO at $23.50 per share. Concentra offers occupational health se...

Cantor Fitzgerald Reiterates Overweight on...
08/20/2024 15:13:18

Cantor Fitzgerald analyst Sarah James reiterates Surgery Partners (NASDAQ:SGRY) with a Overweight and maintains $43 price ta...

What 8 Analyst Ratings Have To Say About S...
08/19/2024 21:00:38

Cantor Fitzgerald Reiterates Overweight on...
08/19/2024 15:39:22

Cantor Fitzgerald analyst Sarah James reiterates Surgery Partners (NASDAQ:SGRY) with a Overweight and maintains $43 price ta...

Citigroup Maintains Buy on Surgery Partner...
08/07/2024 19:27:36

Citigroup analyst Jason Cassorla maintains Surgery Partners (NASDAQ:SGRY) with a Buy and lowers the price target from $38 to...

Benchmark Reiterates Buy on Surgery Partne...
08/07/2024 19:17:40

Benchmark analyst Bill Sutherland reiterates Surgery Partners (NASDAQ:SGRY) with a Buy and maintains $50 price target.

RBC Capital Reiterates Outperform on Surge...
08/07/2024 17:23:30

RBC Capital analyst Ben Hendrix reiterates Surgery Partners (NASDAQ:SGRY) with a Outperform and maintains $49 price target.

Surgery Partners Q2 Adj $0.21 Beats $0.20 ...
08/06/2024 11:36:09

Surgery Partners (NASDAQ:SGRY) reported quarterly earnings of $0.21 per share which beat the analyst consensus estimate of $0.2...

riot-platforms--north-face-parent-vf-corp-are-among-11-mid-cap-stocks-that-performed-the-best-last-week-july-14-july-20-are-others-in-your-portfolio

Riot Platforms & North Face Parent V.F. Co...
07/21/2024 16:07:27

Top mid-cap stock performers: VIRT (+30%), VFC (+22%), NFE (+20%), RIOT (+16%), CLVT (+14%), AMN (+14%), BKU (+13%), MARA (+12%...

Surgery Partners shares are trading higher...
07/19/2024 12:32:41

Bloomberg Reported Late Thursday Surgery P...
07/19/2024 12:29:39

Cantor Fitzgerald Reiterates Overweight on...
07/10/2024 15:11:40

Cantor Fitzgerald analyst Sarah James reiterates Surgery Partners (NASDAQ:SGRY) with a Overweight and maintains $43 price ta...

Cantor Fitzgerald Reiterates Overweight on...
07/09/2024 16:07:54

Cantor Fitzgerald analyst Sarah James reiterates Surgery Partners (NASDAQ:SGRY) with a Overweight and maintains $43 price ta...

Cantor Fitzgerald Reiterates Overweight on...
07/02/2024 15:39:57

Cantor Fitzgerald analyst Sarah James reiterates Surgery Partners (NASDAQ:SGRY) with a Overweight and maintains $43 price ta...

Critical Insights From Surgery Partners An...
06/28/2024 12:00:16

Macquarie Initiates Coverage On Surgery Pa...
06/28/2024 10:59:51

Macquarie analyst Tao Qiu initiates coverage on Surgery Partners (NASDAQ:SGRY) with a Outperform rating and announces Price ...

Citigroup Maintains Buy on Surgery Partner...
05/08/2024 19:11:14

Citigroup analyst Jason Cassorla maintains Surgery Partners (NASDAQ:SGRY) with a Buy and lowers the price target from $42 to...

why-beyond-shares-are-trading-lower-by-over-20-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Why Beyond Shares Are Trading Lower By Ove...
05/07/2024 18:35:21